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ABSTRACT
Hereditary cancer refers to cancers caused by germline mutations in cancer-
predisposing genes. These mutations confer a significantly increased risk of 
cancer are rare and in the majority of cases, autosomal-dominantly inherited.  
Since the eighties of last century more than 115 cancer-predisposing genes 
have been identified. In many Western countries genetic testing of patients and 
families with clustering of cancers started early, and was often performed by 
clinical geneticists (MDs performed the counselling and pedigree analyses) and 
by molecular biologists (in laboratories within departments of clinical genetics).  
It turned out to be a long path to fully realize the promise of cancer-predisposing 
genes. The clinical utility of many cancer genetics tests and subsequent risk to 
reduce interventions has not yet been validated and has several pitfalls, e.g. 
misinterpretation of genetic variants found. However, without doubt genetic 
testing for mutations will eventually turn out as a important tool to save lives 
from early cancer-related death and become part of standard cancer care 
throughout the developed world. Apart from primary surgical prevention, major 
progress is to be expected in earlier diagnoses, tailored therapies, and possibly 
chemoprevention. Ideally, researchers, clinical geneticists, molecular biologists, 
surgeons, oncologists, gynaecologists, and other professionals will work together 
to reach this goal. 
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